(Q37130450)

18 August 2017

1 reference

title

STEP trial and HIV-1 vaccines inducing T-cell responses (English)

1 reference

18 August 2017

0 references

Tomás Hanke

1

1 reference

18 August 2017

publication date

1 April 2008

1 reference

Expert Review of Vaccines

18 August 2017

published in

1 reference

18 August 2017

volume

7

1 reference

18 August 2017

issue

3

1 reference

18 August 2017

page(s)

303-309

1 reference

GP120: target for neutralizing HIV-1 antibodies

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.303

Quantitative adenovirus neutralization assays based on the secreted alkaline phosphatase reporter gene: application in epidemiologic studies and in the design of adenovector vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.303

Detection of antibodies against adenovirus protein IX, fiber, and hexon in human sera by immunoblot assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.303

Adenovirus types 5 and 35 seroprevalence in AIDS risk groups supports type 35 as a vaccine vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.303

Effect of preexisting immunity to adenovirus human serotype 5 antigens on the immune responses of nonhuman primates to vaccine regimens based on human- or chimpanzee-derived adenovirus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.303

Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.303

Identification of a major co-receptor for primary isolates of HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.303

CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.303

The V3 domain of the HIV-1 gp120 envelope glycoprotein is critical for chemokine-mediated blockade of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.303

Enhanced SIV replication and accelerated progression to AIDS in macaques primed to mount a CD4 T cell response to the SIV envelope protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.303

Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.303

Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.303

Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.303

Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.303

HIV: current opinion in escapology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.303

A whole-genome association study of major determinants for host control of HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.303

Attenuation of simian immunodeficiency virus SIVmac239 infection by prophylactic immunization with dna and recombinant adenoviral vaccine vectors expressing Gag

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.303

Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.303

Immune responses in HIV-exposed seronegatives: have they repelled the virus?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.303

HIV-1-specific CTLs effectively suppress replication of HIV-1 in HIV-1-infected macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.303

Plasma viral load, CD4 cell percentage, HLA and survival of HIV-1, HIV-2, and dually infected Gambian patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.303

Sensitive detection of human cytomegalovirus peptide-specific cytotoxic T-lymphocyte responses by interferon-gamma-enzyme-linked immunospot assay and flow cytometry in healthy individuals and in patients after allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.303

Human immunodeficiency virus type 1-specific immune responses in primates upon sequential immunization with adenoviral vaccine carriers of human and simian serotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.303

Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.303

Impact of antigen expression kinetics on the effectiveness of HIV-specific cytotoxic T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.303

How important is the 'quality' of the cytotoxic T lymphocyte (CTL) response in protection against HIV infection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.303

Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.303

HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.303

Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.303

Phenotypic heterogeneity of antigen-specific CD4 T cells under different conditions of antigen persistence and antigen load

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.303

Cytomegalovirus (CMV)-specific cellular immune responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.303

Toll-like receptor 3 promotes cross-priming to virus-infected cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.303

Immunity and immunological memory following smallpox vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.303

Vaccine route, dose and type of delivery vector determine patterns of primary CD8+ T cell responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.303

Can successful vaccines teach us how to induce efficient protective immune responses?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.303

Translating innate immunity into immunological memory: implications for vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.303

Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.303

Induction of multifunctional human immunodeficiency virus type 1 (HIV-1)-specific T cells capable of proliferation in healthy subjects by using a prime-boost regimen of DNA- and modified vaccinia virus Ankara-vectored vaccines expressing HIV-1 Gag c

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.303

An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.303

Immunogenicity of heterologous prime-boost regimens involving recombinant adenovirus serotype 11 (Ad11) and Ad35 vaccine vectors in the presence of anti-ad5 immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.303

Multiple immunizations with adenovirus and MVA vectors improve CD8+ T cell functionality and mucosal homing

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.303

Cytotoxic T-lymphocyte escape does not always explain the transient control of simian immunodeficiency virus SIVmac239 viremia in adenovirus-boosted and DNA-primed Mamu-A*01-positive rhesus macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.303

Vaccine-induced cellular immune responses reduce plasma viral concentrations after repeated low-dose challenge with pathogenic simian immunodeficiency virus SIVmac239

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.303

Design and pre-clinical evaluation of a universal HIV-1 vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.303

Diversity considerations in HIV-1 vaccine selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.303

Polyvalent vaccines for optimal coverage of potential T-cell epitopes in global HIV-1 variants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.303

Coping with viral diversity in HIV vaccine design

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.303

Reconstruction and Function of Ancestral Center-of-Tree Human Immunodeficiency Virus Type 1 Proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.303

Identification of highly conserved and broadly cross-reactive HIV type 1 cytotoxic T lymphocyte epitopes as candidate immunogens for inclusion in Mycobacterium bovis BCG-vectored HIV vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.303

Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 candidate vaccine delivered by a replication-defective recombinant adenovirus vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.303

Evolutionary and immunological implications of contemporary HIV-1 variation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.303

Control of human immunodeficiency virus type 1 is associated with HLA-B*13 and targeting of multiple gag-specific CD8+ T-cell epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.303

Broad and Gag-biased HIV-1 epitope repertoires are associated with lower viral loads

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.303

Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.303

Correlation between immunologic responses to a recombinant glycoprotein 120 vaccine and incidence of HIV-1 infection in a phase 3 HIV-1 preventive vaccine trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.303

Cautious optimism for new HIV/AIDS prevention strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.303

Comparison of the efficacy of early versus late viral proteins in vaccination against SIV

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.303

CD8+ T-cell responses to different HIV proteins have discordant associations with viral load

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.303

Most antiviral CD8 T cells during chronic viral infection do not express high levels of perforin and are not directly cytotoxic

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.303

21 January 2018

Identifiers

DOI

10.1586/14760584.7.3.303

1 reference

18 August 2017

1 reference